Mustang Bio, Inc. - MBIO Net Assets per Single Share

Graphic logo of Mustang Bio (MBIO)

The published book value per share of Mustang Bio, Inc. (MBIO) demonstrates the impact of net losses from early CAR-T therapy trials on equity. The value 1.01 captures the current state of the parameter. Mustang Bio, Inc. (MBIO) develops advanced onco-hematology treatments through cell modification. Management possesses deep scientific expertise, although financial stability relies on asset realization.

Mustang Bio, Inc. (MBIO) Equity per Share: for the period 07/04/2022 - 10/28/2026

Mustang Bio Inc - analytical breakdowns and key metrics (MBIO)

- price and consensus price forecast:
Stock Price Mustang Bio Corp|MBIO - Analyst Median Target
- market capitalization data:
Market Value Mustang Bio, Inc.|MBIO - Total Enterprise Value
- book capitalization data:
Book Value per Share Mustang Bio|MBIO - Accounting Capitalization|Market Value to Book Value Ratio mustangbio.com|MBIO - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Mustang Bio, Inc.|MBIO - Long-Term Debt to Capital|Short-Term Debt to Equity Mustang Bio Corp|MBIO - Company Total Debt|Debt to Book Value Mustang Bio, Inc.
Initial company analysis:mustangbio.com (MBIO)
Manufactured products of Mustang Bio Corp

For Mustang Bio, Inc. (MBIO), the critical capital burn associated with CAR-T platform development makes monitoring residual assets a key factor in assessing financial viability. Net book value per share is calculated as the difference between all assets and liabilities divided by the number of shares, allowing investors to use this chart to determine the real value of the company's assets in the event of liquidation.

Competitor analysis for Mustang Bio, Inc.

Book Value per Share TEM (Tempus AI, Inc.)|QGEN: Net Assets per Share|Net Assets per Single Share IONS|repligen.com (RGEN) - Net Asset Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|TWST: Net Assets per Single Share|10x Genomics Inc (TXG) - Accounting Value per Share|NTLA: Accounting Value per Share|STOK (Stoke Corp) - Book Value per Share|BLFS: Net Assets per Single Share|Net Assets per Share wavelifesciences.com (WVE)|Accounting Value per Share Maze Therapeutics|Book Price of a Share Sionna Therapeutics, Inc. (SION)|Book Value per Share PRME (Prime Medicine Corp)|Taysha Corp - Book Value per Share|uniQure N.V. (QURE) - Net Assets per Single Share|MGTX - Equity per Share|Book Value per Share RGNX (REGENXBIO)|Book Value of One Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp|Book Value per Share Benitec Biopharma Inc. (BNTC)|Net Assets per Single Share designtx.com (DSGN)|Book Value per Share RCKT|4DMT - Net Assets per Share|LXEO (Lexeo) - Net Assets per Single Share|Korro Bio, Inc. (KRRO) - Net Asset Value per Share|Accounting Value per Share Editas Medicine, Inc. EDIT|silence-therapeutics.com (SLN) - Accounting Value of a Share|PRQR: Book Value per Share|Net Assets per Share CDXS|Net Assets per Single Share Sangamo SGMO|Equity per Share nautilus.bio (NAUT)|Metagenomi, Inc. - Book Value per Share|DTIL - Accounting Value per Share|Accounting Value per Share GBIO (Generation Bio Corp)|BOLD: Net Assets per Share|XCUR (exicuretx.com) - Net Assets per Single Share|Imunon (IMNN) - Accounting Value per Share|Book Value per Share Phio Pharmaceuticals Corp|Net Assets per Single Share TransCode|BNGO (Bionano Genomics, Inc.) - Book Value per Share|Net Assets per Share APDN (Applied DNA Sciences Inc)|BLUE: Net Assets per Single Share|Net Asset Value per Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics (OMGA) - Book Value per Share|OMIC: Equity per Share|Net Assets per Single Share Regulus Therapeutics Inc.|Syros Pharmaceuticals Inc. (SYRS) - Equity per Share|TBIO (Codex DNA) - Book Value per Share|Book Value per Share TCON|Net Assets per Single Share UBX (Unity Biotechnology)